rs148736697
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_153700.2(STRC):āc.4432A>Cā(p.Thr1478Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000861 in 1,613,670 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_153700.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STRC | NM_153700.2 | c.4432A>C | p.Thr1478Pro | missense_variant | 23/29 | ENST00000450892.7 | NP_714544.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STRC | ENST00000450892.7 | c.4432A>C | p.Thr1478Pro | missense_variant | 23/29 | 5 | NM_153700.2 | ENSP00000401513 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000467 AC: 71AN: 152008Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000103 AC: 26AN: 251418Hom.: 0 AF XY: 0.0000810 AC XY: 11AN XY: 135882
GnomAD4 exome AF: 0.0000465 AC: 68AN: 1461662Hom.: 0 Cov.: 32 AF XY: 0.0000413 AC XY: 30AN XY: 727146
GnomAD4 genome AF: 0.000467 AC: 71AN: 152008Hom.: 0 Cov.: 31 AF XY: 0.000485 AC XY: 36AN XY: 74232
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 25, 2018 | Variant classified as Uncertain Significance - Favor Benign. The p.Thr1478Pro va riant in STRC has not been previously reported in individuals with hearing loss, but has been identified in 0.2% (41/24010) of African chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs1487366 97). Although this variant has been seen in the general population, its frequenc y is not high enough to rule out a pathogenic role. Computational prediction too ls and conservation analysis do not provide strong support for or against an imp act to the protein. In summary, while the clinical significance of the p.Thr1478 Pro variant is uncertain, its frequency suggests that it is more likely to be be nign. ACMG/AMP Criteria applied: BS1_Supporting. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 05, 2023 | The c.4432A>C (p.T1478P) alteration is located in exon 23 (coding exon 23) of the STRC gene. This alteration results from a A to C substitution at nucleotide position 4432, causing the threonine (T) at amino acid position 1478 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at